Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This one is even More Classic.....
https://www.globenewswire.com/fr/news-release/2016/12/22/901271/0/en/Cellceutix-Wishes-Shareholders-Happy-Holidays-Prepares-for-2017-Focused-on-Partnerships.html
It's no longer on the website (because it talks about Prurisol) but it is worth a read.
http://www.ipharminc.com/press-release
If brilacidin could have helped anyone, something that has never been adequately established, only one person is to blame.
Been a long time since we saw one of these:
http://www.ipharminc.com/new-blog/2018/11/22/innovation-pharmaceuticals-wishes-shareholders-a-happy-thanksgiving
I asked "What is the meaning of this?!?" and you answered that "The USA FDA approval is for the laser surgery instrument."
You didn't identify "the laser surgery instrument" (neither has the Company) and I asked what the the predicate invention was and didn't get an answer.
It reminded me somehow of this exchange from earlier this year when you seemed to think that the CEO's abandonment of 11M of his Class B shares, which had been earlier touted as protection against an unwanted takeover, was a good thing. I asked about it and heard nothing back.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170899446
Now, as the tax year comes to an end, I'm wondering if you think the CPA will be abandoning his last 4.3M Class B shares....the only ownership in IPIX that he has retained?
Finally, can you think of a reason why the CEO of this Company has chosen to hold zero Class A shares while you have continued to accumulate them?
("I am happy I bought an other big bag full of Ipix action below USD$.015"..... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171645380 )
"I'll be back in at 001"
What did you sell out at? I missed that post.
The largest "Sell" so far today was for 175,000 shares valued at $892.50. Was that your big bet or did you roll the dice for something less? Dollar cost averaging is a viable strategy.....as long as the shares eventually go up.
By the way I've quoted Ihub on this issue at least 3 times:
"Trade definitions are based on the mid-price and are indicative only"
Hopefully you'll understand what that means and why it's done someday soon....hopefully before you reassert your conclusion that "no one is really selling even if they come up as sells".
As you know the following was linked via a line described as "Summary" on the 510(k) Premarket Notification for the Manta equipment:
https://www.accessdata.fda.gov/cdrh_docs/pdf22/K222701.pdf
I expect that you noticed that the latest 510(k) Premarket Notification doesn't have a Summary line on it. If it did we would know what BeaMed material was covered and the predicate(s) for it.
https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-notification-510k
"There is no 510(k) form; however, 21 CFR 807 Subpart E describes requirements for a 510(k) submission."
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=807&showFR=1&subpartNode=21:8.0.1.1.5.5
The Company would have had to supply the "missing" information to the FDA. I have no idea why that submission wasn't included or for that matter whether it is typically included int the public filing of the Notification, but obviously it WAS included in the Manta Notification.
When will you be answering this?
"What's the meaning of the info at the link?"
https://investorshub.advfn.com/boards/manage_msg.asp?message_id=173455181
Just ask the person who gave you the link....but I'll bet they don't know either.
I did. I don't.
"Blast off count down beginning tomorrow."
"Tomorrow" was yesterday. How'd it go?
Oh that's right:
0.0043
0.0003 (7.50%)
Volume: 400,940
Total Trades: 24
Dollar Volume: $1,716
That's some blast off. Frothy but down?
Glad somebody is keeping track.
Good call!
Didn't find it. Just posted it. Can't explain what it's for.
Smart boss. The epitome of beating a dead horse.
If he/she is hiring I work pretty cheap and there's less cleaning up to do here every day so I have some spare time.
Not a question of honesty. I could only stand your relentless pressure for so long so I finally I gave in. My boss is gonna be royally pissed. Besides, I knew you would believe anything I told you....after all, you're an IPIX shareholder and hence supremely gullible.
Just ask this guy:
"Blast off count down beginning tomorrow. Any shares you can at these heavily manipulated prices will be Gold in your bank."
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0043
0.0003 (7.50%)
Volume: 400,940
Total Trades: 24
Dollar Volume: $1,716
Frothy.
I don't really. My boss feeds me the questions and I just post 'em. Just like you post your discoveries when a certain party provides them to you, like this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173454745
No one in their right mind would believe that you found that on your own.
That's kind of why I asked. Any idea how one can find the version of this applicable to the current 510(K)?
https://www.accessdata.fda.gov/cdrh_docs/pdf22/K222701.pdf
"The USA FDA approval is for the laser surgery instrument."
Is it? That's all I wanted to know.
Do you know what the specific predicate device was?
What's the meaning of the info at the link?
Obviously we aren't getting it. The entire market is wrong about the value of IPIX....only une petite handful of people have it figured out. The market'll get it right eventually....just wait and see.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.004
-0.001 (-20.00%)
Volume: 611,401
Total Trades: 30
Daily Volume: $2,884
Only a matter of time.
His last voluntary public statement appears to have been made in August. I guess he's busy.
Seems he's been busy for a while. From the current OTCMarkets:
BUSINESS DESCRIPTION
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
ps. I didn't make this up:
"candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future"
Maybe a gag order isn't such a bad idea.
Last I heard the 36 healthy patients had been recruited and that's all I heard.
2nd request:
Please consider adding this as a Sticky: https://ctri.nic.in/Clinicaltrials/showallp.php?mid1=67454&EncHid=&userName=Karveer Meditech
"I think it safe to say that a great majority of ADVFN Plc revenue is derived from advertising and franchise fees."
Maybe so. The fact remains that I make a financial contribution and you freeload...it surprises me not that you can't see how those things are connected.
"I also think it safe to say the primary reason you subscribe is for access to the search feature"
Absolutely (although there are other helpful features). Not only for the purpose of catching people trying to revise history but also to have ready access to the Company's past as it has been chronicled here. BTW, it's very difficult to search your posts and find anything relevant to the operations of the Company. A free membership doesn't preclude such things, you know.
"Oh well, I don't mind."
You don't mind what?
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0052
0.0003 (6.12%)
Volume: 394,545
Total Trades: 40
Daily Volume: $1,940
"He has paid to post anything he likes on this board"
Bullshit. While you and he are free to post on this board (not exactly everything you like, btw....there are a few rules), neither of you has paid for the privilege. Others (ahem) are funding your posting privileges.
I don't mind, but it would be nice to see some meaningful content once in a while to the extent that you are capable.
I'll get you started:
I like IPIX because.....
25 convincing words or less will do. Maybe talk about the drug development progress or the financial status or even something about what you feel "about the future of IPIX".....I don't mind a little RELEVANT science fiction.
From where I sit:
There are no active clinical trials. The few development partners have bailed.
There's very little cash in the till, no accessible registration statement in place so the paucity of available shares can't be sold, and no prospects for a lender. There has not even been the kind of hint that there's a clamoring to buy IPIX assets as we used to see buried in a filing.
The future's not ours to see, que sera, sera (just ask Snowy).
Go!
Thanks. But why do you never write about IPIX?
Is it really "because I don't believe I know any more about the future of IPIX than anyone frequenting the IPIX board"?
"I'm going to pretend for a moment that you asked me about why I maintain the stance that I do."
Who would ask you that? If you actually have a stance it is very well disguised.
"Based on the above facts I can't imagine my having any sinister value worth compensating much less putting me on some sort of regular payroll."
What facts? Me neither.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0049
-0.0007 (-12.50%)
Volume: 253,099
Total Trades: 17
Daily Volume: $ 1,351
Avg trade execution....$79.47
The thing's a gold mine.
"Posted by airplane guy:
The good news is that Polymedix tested Bril against 11 types of weaponized anthrax strains and it stopped every strain it was tested against. "
Just a few notes:
Neither Polymedix nor brilacidin were mentioned in the article linked in the post, which was from 2010 and which you chose not to link, nor does it mention that brilacidin was tested against 11 types of weaponized anthrax strains and that it stopped every strain it was tested against.
The word "anthrax" doesn't turn up in a search of the IPIX website or any of the press releases linked therein.
Do you know what the phrase "low hanging fruit" means?
"why exactly are you here"
There it is again....the question that wouldn't die. It should though, because the fact that this thing (IPIX) hasn't been able to get out of his own way hasn't had anything to do with who is here and who isn't. The Company's price performance matches its operating performance perfectly.
Yep. More than twice as many as he could have added just a year ago. Patience pays off sometimes.
"They have done all they say they will do and they meet their schedules and they do not spend much money."
The financials that they provide to IPIX suggest that they kinda don't spend much money (specifically they spent about 25% of the ipix investment between 6/22 and 9/23) but CEO CPA acknowledges that those numbers aren't subject to the same review as IPIX's own numbers.
I noticed yesterday that this appears in the SERIES A PREFERRED SHARE PURCHASE AGREEMENT between IPIX and Beamed, then Squalus:
"The Company (Squalus) has delivered to each Purchaser its audited financial statements for the fiscal years ended December 31, 2020 and December 31, 2021 and its unaudited internal management accounts as of and for the quarter ended March 31, 2022 (collectively, the “Financial Statements”)."
So Squalus HAD auditors at some point. Where'd they go? If they were still around there wouldn't have been any need for this:
"As a result of the assessment of the Company’s internal control over financial reporting as of June 30, 2023, management concluded that the Company’s accounting procedures relevant to an unconsolidated foreign investment are not sufficiently formal that management can determine whether the applicable control objectives are met and adequate documentation supporting the procedures is in place. Specifically, the Company does not have sufficient controls to conclude that data from the unconsolidated foreign investee underlying the Company’s financial statements is captured completely, accurately and timely, in accordance with the Company’s policies and procedures."
Who shitcanned the Squalus auditors and why?
And Dougwur is still free to answer. But whether he does or he doesn't won't change the fact that the TOTAL Dollar Volume of today's trades was $1,239.
Hanukkah?
Hardly anybody did. (Dollar Volume....$1,239.)
I don't know what an LDE is but I knew the date when I typed it.
Cellceutix: December to Be Momentous Month in Company's History
November 24, 2014
https://www.globenewswire.com/en/news-release/2014/11/24/955423/0/en/Cellceutix-December-to-Be-Momentous-Month-in-Company-s-History.html
But where'd it go? The Great Ehraser made it disappear. Poof!
http://www.ipharminc.com/press-release
Guess he meant some other December. Maybe this one?
These are some pretty dark thoughts. Have you shared them with the Company? (http://www.ipharminc.com/contact-us)
"The only thing I can say is that he has a major collective lawsuit if he goes BK and $4 million just went to BeaMed rather than operations for an agreement on Brilacidin. That’s a transfer of assets by any terms knowing may cause the early BK of the company. Then he would have to answer to why he didn’t state Brilacidin as not effective and the investment to BeaMed is doubly catastrophic to share holders."
That's the first time I've seen you say that brilacidin is ineffective.
OK, so no bubbles no troubles then. But expected since when?
On September 23 there was still hope expressed here: "And the Alfasigma Brilacidin license is worth USD$24 million after milestones. Plus royalty."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172909484&txt2find=alfasigma
Is this what you mean by expected?
" The Company recently learned that Alfasigma is considering terminating further work under the License Agreement, although as of the date of this report, Alfasigma has not notified the Company of the termination of the License Agreement or a cessation of further work under the License Agreement."
That's from the CEO himself 2 weeks ago.
Are you braggin' or complainin'?
IPIX is now free to pursue this:
https://static1.squarespace.com/static/5715352e20c647639137f992/t/5beac1250ebbe846eb4b031e/1542111528589/IPI+IBD+Innovate+2018+Poster+%28final%29.pdf
All the CEO CPA has to do is scrape together some funds and duplicate those results, no? Maybe he can terminate the unfiled BeaMed Agreement by returning some preferred shares and get some cash back.
Of course if it was that easy I guess AlfaSigma wouldn't have bailed.
Hold on. Would you like to suggest that AS was afraid that IPIX would hurt their procspects by breaking out its vaunted oral B fo IBD?
Notice of Annual Meeting of Stockholders
To Be Held on Saturday, January 13, 2024
To Our Stockholders:
NOTICE IS HEREBY GIVEN, that the Annual Meeting of Stockholders (the “Annual Meeting”), of NanoViricides, Inc. (the “Company” or “NanoViricides”) will be held on Saturday, January 13, 2024, at 10:00 a.m., Eastern Daylight Time, at Hampton Inn & Suites Stamford, 26 Mill River Street, Stamford, CT 06902, for the following purposes:
1. To re-elect Anil Diwan as a Class I director for a two-year term expiring at the 2025 annual meeting of stockholders and until his successor is duly elected and qualified or until their earlier resignation or removal (Proposal 1);
2. To conduct an advisory vote on the compensation of the Company’s named Executive Officers (Proposal 2);
3. To approve an award of 10,204 shares of Series A Convertible Preferred Stock to Anil Diwan in connection with the extension of his employment as the Company’s President (Proposal 3);
4. To ratify the appointment of EisnerAmper, LLP, the Company’s independent registered accounting firm for the fiscal year ending June 30, 2024 (Proposal 4); and
5. To transact such other business as may properly come before the Annual Meeting, including to consider any procedural matters incident to the conduct of the Annual Meeting, such as the postponement of the Annual Meeting in order to solicit additional proxies to vote in favor of the matters presented at the Annual Meeting.
"The Company’s Board of Directors (the “Board of Directors”) has fixed the close of business on November 13, 2023, as the record date for the determination of holders of record of the Company’s common stock entitled to notice of, and to vote at, the Annual Meeting. A list of shareholders of record of the Company as of the record date will remain open for inspection during the Annual Meeting until the closing of the polls thereat."
"If Alfasigma were to terminate the License Agreement or cease further work under the License Agreement, the Company could be required to impair some or all of the patent assets associated with Brilacidin."
The good news for shareholders is that most of their patent assets have already been charged off.
Yep. Spanky and the Gang skimmed 82 bucks worth of bottles and cans out of the local recycling boxes. Gonna get some new plywood for the clubhouse with their profits.